March 16th 2023
Look for fluctuating vision, test objectively and keep a few effective tools at your disposal to treat OSD.
Identifying herpesvirus DNA in corneal grafts
January 10th 2023Recent research suggests the need for routine HSV-1 and VZV PCR testing in all explanted corneas regardless of clinical suspicion to detect, treat, and prevent possible recurrence of herpes infection in corneal grafts and support graft survival.
2023: What ophthalmologists in Europe anticipate for the year ahead
December 12th 2022Members of the Ophthalmology Times Europe® Editorial Advisory Board were asked to predict developments in their ophthalmic specialties and interests for 2023. A focus is our ageing population, while efficiency and productivity are also on their minds. The board members agree that one of the major challenges in the year to come will be the large number of patients awaiting diagnosis and treatment, which is only going to increase with the rising average life expectancy worldwide.
The pathophysiology and pathomorphology of corneal ectasia: Part 4
November 14th 2022Corneal cross-linking (CXL) is improving all the time, although all protocols retain the basic requirements for oxygen, riboflavin and UV light. Recent developments mean that CXL at the slit lamp is feasible, which will improve access to the procedure.
Corneal ectasia part 3: OCT epithelial thickness measurements allow monitoring of corneal changes
September 28th 2022The epithelium adapts to compensate for changes in the cornea and these changes can be detected with high sensitivity, reducing both false positives and false negatives in the diagnosis of keratoconus.
Enrolment begins in Phase 2 study for therapeutic for persistent corneal epithelial defects
July 10th 2022Kiora Pharmaceuticals announced it has enrolled the first patient as a part of a Phase 2 study evaluating KIO-201 topical eye drops in patients with PCED, a rare ocular surface condition characterized by non-healing wounds on the eye surface.